Panaccione R - Search Results

1

Adalimumab for the treatment of fistulas in patients with Crohn's disease.

Colombel JF, Schwartz DA, Sandborn WJ, Kamm MA, D'Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J, Kent JD, Lomax KG, Pollack PF. Colombel JF, et al. Among authors: panaccione r. Gut. 2009 Jul;58(7):940-8. doi: 10.1136/gut.2008.159251. Epub 2009 Feb 6. Gut. 2009. PMID: 19201775 Free PMC article. Clinical Trial.

2

Is antibody testing for inflammatory bowel disease clinically useful?

Panaccione R, Sandborn WJ. Panaccione R, et al. Gastroenterology. 1999 Apr;116(4):1001-2; discussion 1002-3. doi: 10.1016/s0016-5085(99)70087-9. Gastroenterology. 1999. PMID: 10092326 No abstract available.

3

The appendix in ulcerative colitis: a not so innocent bystander.

Panaccione R, Sandborn WJ. Panaccione R, et al. Gastroenterology. 1999 Jul;117(1):272-3. doi: 10.1016/s0016-5085(99)70581-0. Gastroenterology. 1999. PMID: 10381940 No abstract available.

4

Successful management of Crohn's disease of the ileoanal pouch with infliximab.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: panaccione r. Gastroenterology. 1999 Aug;117(2):429-32. doi: 10.1053/gast.1999.0029900429. Gastroenterology. 1999. PMID: 10419926

5

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: panaccione r. Am J Gastroenterol. 2001 Mar;96(3):722-9. doi: 10.1111/j.1572-0241.2001.03612.x. Am J Gastroenterol. 2001. PMID: 11280541

6

Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.

Feagan BG, Enns R, Fedorak RN, Panaccione R, Paré P, Steinhart AH, Wild G. Feagan BG, et al. Among authors: panaccione r. Can J Clin Pharmacol. 2001 Winter;8(4):188-98. Can J Clin Pharmacol. 2001. PMID: 11743591 Review.

7

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. Schwartz DA, et al. Among authors: panaccione r. Gastroenterology. 2002 Apr;122(4):875-80. doi: 10.1053/gast.2002.32362. Gastroenterology. 2002. PMID: 11910338

8

Medical therapy of Crohn disease.

Panaccione R, Sandborn WJ. Panaccione R, et al. Curr Opin Gastroenterol. 2004 Jul;20(4):351-9. doi: 10.1097/00001574-200407000-00009. Curr Opin Gastroenterol. 2004. PMID: 15703664

9

Natalizumab induction and maintenance therapy for Crohn's disease.

Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, Panaccione R, Sanders M, Schreiber S, Targan S, van Deventer S, Goldblum R, Despain D, Hogge GS, Rutgeerts P; International Efficacy of Natalizumab as Active Crohn's Therapy (ENACT-1) Trial Group; Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group. Sandborn WJ, et al. Among authors: panaccione r. N Engl J Med. 2005 Nov 3;353(18):1912-25. doi: 10.1056/NEJMoa043335. N Engl J Med. 2005. PMID: 16267322 Free article. Clinical Trial.

10

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P. Hanauer SB, et al. Among authors: panaccione r. Gastroenterology. 2006 Feb;130(2):323-33; quiz 591. doi: 10.1053/j.gastro.2005.11.030. Gastroenterology. 2006. PMID: 16472588 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters